Rabbit Polyclonal CD208 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 13 publications. Immunogen corresponding to Synthetic Peptide within Human LAMP3.
View Alternative Names
CD208, DCLAMP, TSC403, LAMP3, Lysosome-associated membrane glycoprotein 3, LAMP-3, Lysosomal-associated membrane protein 3, DC-lysosome-associated membrane glycoprotein, Protein TSC403, DC LAMP
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD208 antibody (AB111090)
ab111090 at 1/50 dilution staining CD208 in paraffin-embedded Human Lung carcinoma tissue by Immunohistochemistry. The image on the right is treated with the synthesized peptide.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD208 participates in the regulation of the immune response by facilitating antigen processing and presentation. This protein is a part of the lysosomal-associated membrane protein family which contributes to the recycling of MHC class II molecules. Through its involvement in the endocytic pathway CD208 aids in presenting antigens to T lymphocytes an important step in triggering adaptive immunity. The protein colocalizes with MHC class II which is essential for effective antigen presentation.
Pathways
CD208 has a significant role in the endosomal-lysosomal pathway where it interacts with other proteins involved in antigen processing. It also engages in the intracellular trafficking pathway that affects the presentation of peptides on MHC class II molecules. The interaction with proteins such as HLA-DR is vital for efficient antigen presentation to helper T cells. CD208 supports the proper delivery of peptide-loaded MHC molecules to the cell surface a necessity for a functional adaptive immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Cellular oncology (Dordrecht, Netherlands) 48:1127-1144 PubMed40498284
2025
Applications
Unspecified application
Species
Unspecified reactive species
Computational and structural biotechnology journal 23:1201-1213 PubMed38545600
2024
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 4:101961 PubMed36633948
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 12:e1072 PubMed36305631
2022
Applications
Unspecified application
Species
Unspecified reactive species
IUBMB life 73:1334-1347 PubMed34415102
2021
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33:10490-10504 PubMed31311326
2019
Applications
Unspecified application
Species
Unspecified reactive species
Breast cancer research : BCR 21:46 PubMed30922380
2019
Applications
Unspecified application
Species
Unspecified reactive species
Clinical lymphoma, myeloma & leukemia 18:749-754 PubMed30082222
2018
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2017:1218254 PubMed28607528
2017
Applications
IHC-P
Species
Human
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 39:1010428317695014 PubMed28349821
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com